Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Gusperimus - Nippon Kayaku

Next Previous
X
Search
Drug Profile

Gusperimus - Nippon Kayaku

Alternative Names: 15-Deoxyspergualin; BMS 181173; BMY 422151; Deoxyspergualin; Deoxyspurgiline; DSG; Heptanamide; NKT 301; NKT-01; NSC 356894; Spandin injection; Spandin®; Spanidin; Spanidin injection

Latest Information Update: 07 Jan 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Institute of Microbial Chemistry
  • Developer Nippon Kayaku; Nordic Group
  • Class Cytostatic antibiotics; Guanidines; Small molecules
  • Mechanism of Action Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Granulomatosis with polyangiitis
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Renal transplant rejection
  • Discontinued Cancer; Diabetes mellitus; Glomerulonephritis; Granulomatosis with polyangiitis; Hypersensitivity; Immunological disorders; Multiple sclerosis; Rheumatoid arthritis; Systemic lupus erythematosus

Most Recent Events

  • 31 Mar 2014 Nordic Pharma suspends enrolment in the phase III SPARROW trial for Wegener's granulomatosis in Czech Republic, Germany, Sweden and Spain (NCT01446211)
  • 19 Jan 2012 Phase-III clinical trials in Wegener's granulomatosis (recurrent) in Germany, Sweden, Spain and United Kingdom (SC) after January 2012
  • 19 Jan 2012 Nordic Pharma initiates enrolment in a phase III trial for Wegener's granulomatosis (recurrent) in Czech Republic (NCT01446211)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top